Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.
Koeneman KS, Yeung F, Chung LW. Koeneman KS, et al. Prostate. 1999 Jun 1;39(4):246-61. doi: 10.1002/(sici)1097-0045(19990601)39:4<246::aid-pros5>;2-u. Prostate. 1999. PMID: 10344214 Review.
Cellular interactions in the tropism of prostate cancer to bone.
Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW. Sikes RA, et al. Among authors: koeneman ks. Int J Cancer. 2004 Jul 1;110(4):497-503. doi: 10.1002/ijc.20153. Int J Cancer. 2004. PMID: 15122581
Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models.
Li Y, Sikes RA, Malaeb BS, Yeung F, Law A, Graham SE, Pei M, Kao C, Nelson J, Koeneman KS, Chung LW. Li Y, et al. Among authors: koeneman ks. Urol Oncol. 2011 Nov-Dec;29(6):802-8. doi: 10.1016/j.urolonc.2009.09.016. Epub 2010 May 6. Urol Oncol. 2011. PMID: 20451417
Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.
Li Y, Malaeb BS, Li ZZ, Thompson MG, Chen Z, Corey DR, Hsieh JT, Shay JW, Koeneman KS. Li Y, et al. Among authors: koeneman ks. Prostate. 2010 May 1;70(6):616-29. doi: 10.1002/pros.21096. Prostate. 2010. PMID: 20043297 Free PMC article.
The prospect of gene therapy for prostate cancer: update on theory and status.
Koeneman KS, Hsieh JT. Koeneman KS, et al. Curr Opin Urol. 2001 Sep;11(5):489-94. doi: 10.1097/00042307-200109000-00007. Curr Opin Urol. 2001. PMID: 11493770 Review.
Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line.
Cinar B, Koeneman KS, Edlund M, Prins GS, Zhau HE, Chung LW. Cinar B, et al. Among authors: koeneman ks. Cancer Res. 2001 Oct 1;61(19):7310-7. Cancer Res. 2001. PMID: 11585771
Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.
Koeneman KS, Kao C, Ko SC, Yang L, Wada Y, Kallmes DF, Gillenwater JY, Zhau HE, Chung LW, Gardner TA. Koeneman KS, et al. World J Urol. 2000 Apr;18(2):102-10. doi: 10.1007/s003450050181. World J Urol. 2000. PMID: 10854144 Clinical Trial.
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Sagalowsky AI, Cadeddu JA, McConnell JD, Holmes MN, Roehrborn CG. Shariat SF, et al. Among authors: koeneman ks. J Urol. 2004 Mar;171(3):1122-7. doi: 10.1097/01.ju.0000113249.82533.28. J Urol. 2004. PMID: 14767284
Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model.
Canales BK, Li Y, Thompson MG, Gleason JM, Chen Z, Malaeb B, Corey DR, Herbert BS, Shay JW, Koeneman KS. Canales BK, et al. Among authors: koeneman ks. Urol Oncol. 2006 Mar-Apr;24(2):141-51. doi: 10.1016/j.urolonc.2005.11.003. Urol Oncol. 2006. PMID: 16520278
Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z, Koeneman KS, Corey DR. Chen Z, et al. Among authors: koeneman ks. Cancer Res. 2003 Sep 15;63(18):5917-25. Cancer Res. 2003. PMID: 14522918
37 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page